These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 15487854)
21. MATCH results: implications for the internist. Lutsep HL Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967 [TBL] [Abstract][Full Text] [Related]
22. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis. Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900 [TBL] [Abstract][Full Text] [Related]
23. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view. Gebel JM J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120 [TBL] [Abstract][Full Text] [Related]
25. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence. Davis KA; Miyares MA; Dietrich E Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103 [TBL] [Abstract][Full Text] [Related]
26. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials. Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260 [TBL] [Abstract][Full Text] [Related]
27. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY; N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750 [TBL] [Abstract][Full Text] [Related]
28. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks. Hankey GJ; Eikelboom JW Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331 [TBL] [Abstract][Full Text] [Related]
29. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
30. Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study. Weimar C; Cotton D; Sha N; Sacco RL; Bath PM; Weber R; Diener HC Cerebrovasc Dis; 2013; 35(6):538-43. PubMed ID: 23816610 [TBL] [Abstract][Full Text] [Related]
31. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack. Hills NK; Johnston SC Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509 [TBL] [Abstract][Full Text] [Related]
32. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis. Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B Stroke; 2017 Sep; 48(9):2610-2613. PubMed ID: 28701574 [TBL] [Abstract][Full Text] [Related]
33. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review. Simmons BB; Yeo A; Fung K; ; Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455 [TBL] [Abstract][Full Text] [Related]
34. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists]. Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003 [TBL] [Abstract][Full Text] [Related]
35. Safety of clopidogrel and aspirin for stroke prevention: implications of the CHARISMA trial. Ruland S Drug Saf; 2008; 31(6):449-58. PubMed ID: 18484780 [TBL] [Abstract][Full Text] [Related]
36. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. Sacco RL; Diener HC; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; Vandermaelen C; Voigt T; Weber M; Yoon BW; N Engl J Med; 2008 Sep; 359(12):1238-51. PubMed ID: 18753638 [TBL] [Abstract][Full Text] [Related]
37. Aspirin therapy should be first-line treatment in secondary prevention of stroke--against. Diener HC Stroke; 2002 Aug; 33(8):2138-9. PubMed ID: 12154277 [No Abstract] [Full Text] [Related]
38. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack. Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Cao Y; Wang Y J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2074-2081. PubMed ID: 28736132 [TBL] [Abstract][Full Text] [Related]
39. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287 [TBL] [Abstract][Full Text] [Related]
40. Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke. Li J; Wang Y; Wang D; Lin J; Wang A; Zhao X; Liu L; Wang C; Wang Y; Neurology; 2015 Mar; 84(13):1330-6. PubMed ID: 25740863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]